Read + Share
Selmaj KW, Steinman L, Comi G, Bar-Or A, et al. Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final
analysis of the DAYBREAK open-label extension trial. Mult Scler 2025;31:1557-1571.
PMID: 41190505
|
 |
|
Selmaj KW, Steinman L, Comi G, Bar-Or A, et al. Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final
analysis of the DAYBREAK open-label extension trial. Mult Scler 2025;31:1557-1571.
PMID: 41190505
|
|
|
|